Allergy immunotherapy, hypo-sensitization or desensitization, is a preventive therapeutic treatment for the allergic reactions to various allergens including various drugs, foods, bee venom, house dust mites, and grass pollens.

Global Allergy Immunotherapy Market was valued US$ XX Bn in 2018 and is expected to reach US$ 4.15 Bn by 2026, at a CAGR of around XX % during a forecast period.